EZH2 and chronic myelogenous leukemia, BCR-ABL1 positive: Results of RT-qPCR and WB verification indicated the expression levels of EZH2 mRNA and protein in bone marrow cells of CML IM-resistant patients were higher than those of IM-sensitive patients and healthy donors.